Genetic Testing for Diagnosis of Inherited Conditions - Medicare Advantage (Revised)
Effective date
Not stated in the notice
Identified
Jun 30, 2026
Summary
Humana Medicare Advantage has updated its genetic testing policy for diagnosing inherited conditions. The policy clarifies that genetic testing may be performed to detect gene variants and confirm diagnoses in symptomatic patients to aid treatment decisions, with examples including achondroplasia, alpha-1 antitrypsin deficiency, Barth syndrome, and other hereditary conditions. However, the provided content is incomplete (truncated mid-sentence), limiting full analysis of coverage scope and billing implications.
Get alerts when payers change rules like this one
We check Humana and other payers every day and email you when a change matches your specialty and state.
01URGENT - INCOMPLETE POLICY ALERT: By [immediate]: Billing team must obtain the complete policy document from Humana (URL: https://dctm.humana.com/Mentor/Web/v.aspx?objectID=090009298a5698be) as the provided summary is truncated.
02Once full policy is received.
03Identify all specific genetic testing CPT/HCPCS codes covered.
04Determine if prior authorization is required.
05Review medical necessity documentation requirements.
06Update billing system encounter forms and prior auth workflows accordingly.
07DO NOT bill genetic testing claims under this policy until complete guidance is obtained - incomplete policy knowledge will result in claim denials or rejections.
Original notice
Genetic Testing for Diagnosis of Inherited Conditions - Medicare Advantage (Revised)
mcp.humana.com · Always check the source before changing claims.
Summaries are AI-assisted. Always confirm against the original payer notice.
What is PolicyChanges
One workspace for payer rules, prior auth, coding and compliance
Medical practices use PolicyChanges to catch payer changes before they cause denials. Every change is summarized in plain English, with the codes involved, the date it takes effect and what to do.